159 related articles for article (PubMed ID: 37782053)
1. Myeloid Heterogeneity Mediates Acute Exacerbations of Pulmonary Fibrosis.
Larson-Casey JL; Saleem K; Surolia R; Pandey J; Mack M; Antony VB; Bodduluri S; Bhatt SP; Duncan SR; Carter AB
J Immunol; 2023 Dec; 211(11):1714-1724. PubMed ID: 37782053
[TBL] [Abstract][Full Text] [Related]
2. Technical advance: The use of tree shrews as a model of pulmonary fibrosis.
Larson-Casey JL; He C; Che P; Wang M; Cai G; Kim YI; El Hamdaoui M; Grytz R; Ding Q; Carter AB
PLoS One; 2020; 15(11):e0241323. PubMed ID: 33141839
[TBL] [Abstract][Full Text] [Related]
3. Effects of particulate matter from straw burning on lung fibrosis in mice.
Hu Y; Wang LS; Li Y; Li QH; Li CL; Chen JM; Weng D; Li HP
Environ Toxicol Pharmacol; 2017 Dec; 56():249-258. PubMed ID: 29031221
[TBL] [Abstract][Full Text] [Related]
4. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis.
Gibbons MA; MacKinnon AC; Ramachandran P; Dhaliwal K; Duffin R; Phythian-Adams AT; van Rooijen N; Haslett C; Howie SE; Simpson AJ; Hirani N; Gauldie J; Iredale JP; Sethi T; Forbes SJ
Am J Respir Crit Care Med; 2011 Sep; 184(5):569-81. PubMed ID: 21680953
[TBL] [Abstract][Full Text] [Related]
5. Classical monocyte-derived macrophages as therapeutic targets of umbilical cord mesenchymal stem cells: comparison of intratracheal and intravenous administration in a mouse model of pulmonary fibrosis.
Choi SM; Mo Y; Bang JY; Ko YG; Ahn YH; Kim HY; Koh J; Yim JJ; Kang HR
Respir Res; 2023 Mar; 24(1):68. PubMed ID: 36870972
[TBL] [Abstract][Full Text] [Related]
6. Targeting pathogenic macrophages by the application of SHP-1 agonists reduces inflammation and alleviates pulmonary fibrosis.
Hong SY; Lu YT; Chen SY; Hsu CF; Lu YC; Wang CY; Huang KL
Cell Death Dis; 2023 Jun; 14(6):352. PubMed ID: 37291088
[TBL] [Abstract][Full Text] [Related]
7. Myeloid-specific deletion of activating transcription factor 6 alpha increases CD11b
Mekhael O; Revill SD; Hayat AI; Cass SP; MacDonald K; Vierhout M; Ayoub A; Reihani A; Padwal M; Imani J; Ayaub E; Yousof T; Dvorkin-Gheva A; Rullo A; Hirota JA; Richards CD; Bridgewater D; Stämpfli MR; Hambly N; Naqvi A; Kolb MR; Ask K
Immunol Cell Biol; 2023 May; 101(5):412-427. PubMed ID: 36862017
[TBL] [Abstract][Full Text] [Related]
8. The Sphingosine Kinase 1 Inhibitor, PF543, Mitigates Pulmonary Fibrosis by Reducing Lung Epithelial Cell mtDNA Damage and Recruitment of Fibrogenic Monocytes.
Cheresh P; Kim SJ; Huang LS; Watanabe S; Joshi N; Williams KJN; Chi M; Lu Z; Harijith A; Yeldandi A; Lam AP; Gottardi C; Misharin AV; Budinger GRS; Natarajan V; Kamp DW
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764262
[TBL] [Abstract][Full Text] [Related]
9. Exposure to PM
Tahara M; Fujino Y; Yamasaki K; Oda K; Kido T; Sakamoto N; Kawanami T; Kataoka K; Egashira R; Hashisako M; Suzuki Y; Fujisawa T; Mukae H; Suda T; Yatera K
Respir Res; 2021 Mar; 22(1):80. PubMed ID: 33711988
[TBL] [Abstract][Full Text] [Related]
10. Macrophage expressed tartrate-resistant acid phosphatase 5 promotes pulmonary fibrosis progression.
Bergwik J; Bhongir RKV; Padra M; Adler A; Olm F; Lång P; Lindstedt S; Andersson G; Egesten A; Tanner L
Immunology; 2024 Apr; 171(4):583-594. PubMed ID: 38178705
[TBL] [Abstract][Full Text] [Related]
11. VISTA (PD-1H) Is a Crucial Immune Regulator to Limit Pulmonary Fibrosis.
Kim SH; Adams TS; Hu Q; Shin HJ; Chae G; Lee SE; Sharma L; Kwon HK; Lee FY; Park HJ; Huh WJ; Manning E; Kaminski N; Sauler M; Chen L; Song JW; Kim TK; Kang MJ
Am J Respir Cell Mol Biol; 2023 Jul; 69(1):22-33. PubMed ID: 36450109
[TBL] [Abstract][Full Text] [Related]
12. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
[TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine alleviates fine particulate matter (PM2.5)-induced lung injury by attenuation of ROS-mediated recruitment of neutrophils and Ly6C
Lin CM; Huang TH; Chi MC; Guo SE; Lee CW; Hwang SL; Shi CS
Ecotoxicol Environ Saf; 2022 Jul; 239():113632. PubMed ID: 35594827
[TBL] [Abstract][Full Text] [Related]
14. Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality.
Tsitoura E; Trachalaki A; Vasarmidi E; Mastrodemou S; Margaritopoulos GA; Kokosi M; Fanidis D; Galaris A; Aidinis V; Renzoni E; Tzanakis N; Wells AU; Antoniou KM
Front Immunol; 2021; 12():645548. PubMed ID: 34867934
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the molecular mechanisms of Maxing Huoqiao Decoction in treating pulmonary fibrosis via transcriptional profiling and circRNA-miRNA-mRNA network analysis.
Zhao C; Bu E; Zhang C; Lai R; He J; Guo B; Guo W; Liu L; Pan H
Phytomedicine; 2023 Jul; 115():154754. PubMed ID: 37087790
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of OPN contributes to idiopathic pulmonary fibrosis and indicates a poor prognosis.
Ji J; Zheng S; Liu Y; Xie T; Zhu X; Nie Y; Shen Y; Han X
J Transl Med; 2023 Sep; 21(1):640. PubMed ID: 37726818
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of FAPα assessment in bronchoalveolar lavage as a marker of fibrogenesis: results of a preclinical study and first report in patients with idiopathic pulmonary fibrosis.
Lavis P; Pingitore J; Doumont G; Garabet A; Van Simaeys G; Lacroix S; Passon N; Van Heymbeek C; De Maeseneire C; Allard J; Collin A; Huaux F; Decaestecker C; Salmon I; Goldman S; Cardozo AK; Bondue B
Respir Res; 2023 Oct; 24(1):254. PubMed ID: 37880678
[TBL] [Abstract][Full Text] [Related]
18. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
[TBL] [Abstract][Full Text] [Related]
19. IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis.
Chen T; Qiu H; Zhao MM; Chen SS; Wu Q; Zhou NY; Lu LQ; Song JC; Tang DL; Weng D; Li HP
J Cell Mol Med; 2019 Feb; 23(2):908-919. PubMed ID: 30378252
[TBL] [Abstract][Full Text] [Related]
20. Chemokine Receptor 2-targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial.
Brody SL; Gunsten SP; Luehmann HP; Sultan DH; Hoelscher M; Heo GS; Pan J; Koenitzer JR; Lee EC; Huang T; Mpoy C; Guo S; Laforest R; Salter A; Russell TD; Shifren A; Combadiere C; Lavine KJ; Kreisel D; Humphreys BD; Rogers BE; Gierada DS; Byers DE; Gropler RJ; Chen DL; Atkinson JJ; Liu Y
Am J Respir Crit Care Med; 2021 Jan; 203(1):78-89. PubMed ID: 32673071
[No Abstract] [Full Text] [Related]
[Next] [New Search]
